KCT0009122
Not yet recruiting
未知
Clinical study for efficacy and safety of bone marrow derived cell concentrate and allogenic dermal matrix complex therapy in diabetic foot ulcer
Soon Chun Hyang University Hospital Bucheon0 sites58 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Endocrine, nutritional and metabolic diseases
- Sponsor
- Soon Chun Hyang University Hospital Bucheon
- Enrollment
- 58
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •? Patients with intractable foot ulcers due to diabetes measuring between 2 x 2 cm² and less than 12 x 12 cm²
- •? Patients with diabetic foot ulcers that do not heal for 3 weeks despite conventional conventional wound treatment
- •? Patients with diabetic foot ulcers who have ABI \<0\.7 or who have undergone percutaneous angioplasty in cases where the wound exposes bone or tendon accompanied by infection.
- •? Adults over 19 years old, under 70 years old
- •? Those who signed the consent form after receiving an explanation of the purpose, methods, and effects of this study
Exclusion Criteria
- •? Those who have been diagnosed with a malignant blood disease such as lymphoma or leukemia and have not experienced remission
- •? People with severe anemia and other blood diseases
- •? Those who have a history of solid cancer or have been diagnosed with solid cancer and are currently undergoing chemotherapy
- •? Those who have undergone major surgical operations, organ biopsies, or significant trauma at the discretion of the researcher within 3 months prior to registration
- •? Those with active infection
- •? Those who are receiving or are scheduled to receive drugs that, as determined by the researcher, may affect the results
- •? Persons who are unable to comply with the research plan and follow\-up observations
- •? Those who participated in another clinical trial within 30 days before registration
- •? A person who is deemed inappropriate by the researcher to participate in this study.
- •? Those currently taking steroids or immunosuppressants
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer.JPRN-UMIN000015126Department of Urology, Keio University School of Medicine
Completed
Not Applicable
A safety and efficacy study of autologous bone marrow cell transplantation for cirrhosis of liver caused by lifestyle related diseaseCirrhosis of liver caused by lifestyle related disease(Including NASH)JPRN-UMIN000015251Heart life hospital10
Completed
Not Applicable
A safety and efficacy study of autologous bone marrow cell transplantation for HIV positive patients with cirrhosisHIV infection, AIDS, CirrhosisJPRN-UMIN000005174ational Center for Global Health and Medicine10
Completed
Not Applicable
Histomorphometric and immunohistochemical evaluation of beta-tricalcium phosphate of different particles dimensions in maxillary sinus floor elevation: a randomized clinical studyStomatognathic diseasesMaxillary sinusBone substitutesBone resorptionA04.531.621.578D25.130.325C05.116.264RBR-63c3gnFaculdade de Odontologia de Araçatuba
Unknown
Phase 1
Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary CirrhosisPrimary Biliary CirrhosisNCT01440309Robert Chunhua Zhao, MD, PhD20